1 |
SHIM K Y,EOM Y W,KIM M Y,et al.Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension[J]. Korean J Intern Med,2018,33(3):453-461.
|
2 |
GRANZOW M,SCHIERWAGEN R,KLEIN S,et al.Angiotensin-Ⅱ type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis[J]. Hepatology,2014,60(1):334-348.
|
3 |
中华医学会肝病学分会. 肝硬化腹水及相关并发症的诊疗指南[J]. 中华肝脏病杂志,2017,25(9):664-677.
|
4 |
KAMATH P S,WIESNER R H,MALINCHOC M.A model to predict survival in patients with end-stage liver disease[J]. Hepatology,2001,33(2):464-470.
|
5 |
BIGGINS S W,KIM W R,TERRAULT N A,et al.Evidence-based incorporation of serum sodium concentration into MELD[J]. Gastroenterology,2006,130(6):1652-1660.
|
6 |
SIMÕES E SILVA A C,MIRANDA A S,ROCHA N P,et al. Renin angiotensin system in liver diseases:friend or foe?[J]. World J Gastroenterol,2017,23(19):3396-3406.
|
7 |
MOREIRA DE MACÊDO S,GUIMARÃES T A,FELTENBERGER J D,et al. The role of renin-angiotensin system modulation on treatment and prevention of liver diseases[J]. Peptides,2014,62:189-196.
|
8 |
GLIŠI T M,PERIŠI M D,DIMITRIJEVIC S,et al. Doppler assessment of splanchnic arterial flow in patients with liver cirrhosis:correlation with ammonia plasma levels and MELD score[J]. J Clin Ultrasound,2014,42(5):264-269.
|
9 |
GODFREY E L,KUEHT M L,RANA A,et al.MELD-Na(the new MELD) and peri-operative outcomes in emergency surgery[J]. Am J Surg,2018,216(3):407-413.
|
10 |
MALINCHOC M,KAMATH P S,GORDON F D,et al.A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts[J]. Hepatology,2000,31(4):864-871.
|
11 |
HERATH C B,MAK K,BURRELL L M,et al.Angiotensin-(1-7) reduces the perfusion pressure response to angiotensin II and methoxamine via an endothelial nitric oxide-mediated pathway in cirrhotic rat liver[J]. Am J Physiol Gastrointest Liver Physiol,2013,304(1):G99-G108.
|